These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15756259)

  • 1. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma.
    Moberg M; Gustavsson I; Wilander E; Gyllensten U
    Br J Cancer; 2005 Mar; 92(5):891-4. PubMed ID: 15756259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.
    Ylitalo N; Sørensen P; Josefsson AM; Magnusson PK; Andersen PK; Pontén J; Adami HO; Gyllensten UB; Melbye M
    Lancet; 2000 Jun; 355(9222):2194-8. PubMed ID: 10881892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
    Wang M; Hou B; Wang X; Han L; Shi Y; Zhang Y; Zhang L; Liu L; Jin F; Zhang Y
    Cancer Med; 2021 Apr; 10(7):2482-2488. PubMed ID: 33682355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus genotypes in invasive cervical squamous cell carcinoma in Trinidad.
    Hosein F; Mohammed W; Zubach V; Legall G; Severini A
    Rev Panam Salud Publica; 2013 Apr; 33(4):267-70. PubMed ID: 23698175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
    Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
    Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors in invasive cervical cancer among Mexican women].
    Tirado-Gómez LL; Mohar-Betancourt A; López-Cervantes M; García-Carrancá A; Franco-Marina F; Borges G
    Salud Publica Mex; 2005; 47(5):342-50. PubMed ID: 16323527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ.
    Moberg M; Gustavsson I; Gyllensten U
    Int J Cancer; 2004 Dec; 112(5):854-9. PubMed ID: 15386375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients.
    Cao M; Wang Y; Wang D; Duan Y; Hong W; Zhang N; Shah W; Wang Y; Chen H
    Am J Clin Pathol; 2020 Mar; 153(4):502-512. PubMed ID: 31819948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
    Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
    Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
    Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.
    Josefsson AM; Magnusson PK; Ylitalo N; Sørensen P; Qwarforth-Tubbin P; Andersen PK; Melbye M; Adami HO; Gyllensten UB
    Lancet; 2000 Jun; 355(9222):2189-93. PubMed ID: 10881891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
    Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
    J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.